» Articles » PMID: 21906632

Approaches for Defining the Hsp90-dependent Proteome

Overview
Specialties Biochemistry
Biophysics
Date 2011 Sep 13
PMID 21906632
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Hsp90 is the target of ongoing drug discovery studies seeking new compounds to treat cancer, neurodegenerative diseases, and protein folding disorders. To better understand Hsp90's roles in cellular pathologies and in normal cells, numerous studies have utilized proteomics assays and related high-throughput tools to characterize its physical and functional protein partnerships. This review surveys these studies, and summarizes the strengths and limitations of the individual attacks. We also include downloadable spreadsheets compiling all of the Hsp90-interacting proteins identified in more than 23 studies. These tools include cross-references among gene aliases, human homologues of yeast Hsp90-interacting proteins, hyperlinks to database entries, summaries of canonical pathways that are enriched in the Hsp90 interactome, and additional bioinformatic annotations. In addition to summarizing Hsp90 proteomics studies performed to date and the insights they have provided, we identify gaps in our current understanding of Hsp90-mediated proteostasis. This article is part of a Special Issue entitled: Heat Shock Protein 90 (HSP90).

Citing Articles

Organ transformation by environmental disruption of protein integrity and epigenetic memory in Drosophila.

Snir O, Elgart M, Gnainsky Y, Goldsmith M, Ciabrelli F, Dagan S PLoS Biol. 2024; 22(5):e3002629.

PMID: 38805504 PMC: 11161060. DOI: 10.1371/journal.pbio.3002629.


Native Size-Exclusion Chromatography-Based Mass Spectrometry Reveals New Components of the Early Heat Shock Protein 90 Inhibition Response Among Limited Global Changes.

Samant R, Batista S, Larance M, Ozer B, Milton C, Bludau I Mol Cell Proteomics. 2022; 22(2):100485.

PMID: 36549590 PMC: 9898794. DOI: 10.1016/j.mcpro.2022.100485.


Heat Shock Protein 90 Chaperones E1A Early Protein of Adenovirus 5 and Is Essential for Replication of the Virus.

Dalidowska I, Gazi O, Sulejczak D, Przybylski M, Bieganowski P Int J Mol Sci. 2021; 22(4).

PMID: 33670684 PMC: 7921956. DOI: 10.3390/ijms22042020.


Chaperome Networks - Redundancy and Implications for Cancer Treatment.

Yan P, Wang T, Guzman M, Peter R, Chiosis G Adv Exp Med Biol. 2020; 1243:87-99.

PMID: 32297213 PMC: 7279512. DOI: 10.1007/978-3-030-40204-4_6.


The Hsp90 isoforms from S. cerevisiae differ in structure, function and client range.

Girstmair H, Tippel F, Lopez A, Tych K, Stein F, Haberkant P Nat Commun. 2019; 10(1):3626.

PMID: 31399574 PMC: 6689086. DOI: 10.1038/s41467-019-11518-w.


References
1.
Carr S, Aebersold R, Baldwin M, Burlingame A, Clauser K, Nesvizhskii A . The need for guidelines in publication of peptide and protein identification data: Working Group on Publication Guidelines for Peptide and Protein Identification Data. Mol Cell Proteomics. 2004; 3(6):531-3. DOI: 10.1074/mcp.T400006-MCP200. View

2.
Falsone S, Gesslbauer B, Rek A, Kungl A . A proteomic approach towards the Hsp90-dependent ubiquitinylated proteome. Proteomics. 2007; 7(14):2375-83. DOI: 10.1002/pmic.200600996. View

3.
LaCount D, Vignali M, Chettier R, Phansalkar A, Bell R, Hesselberth J . A protein interaction network of the malaria parasite Plasmodium falciparum. Nature. 2005; 438(7064):103-7. DOI: 10.1038/nature04104. View

4.
Gupta N, Pevzner P . False discovery rates of protein identifications: a strike against the two-peptide rule. J Proteome Res. 2009; 8(9):4173-81. PMC: 3398614. DOI: 10.1021/pr9004794. View

5.
Song D, Chaerkady R, Tan A, Garcia-Garcia E, Nalli A, Suarez-Gauthier A . Antitumor activity and molecular effects of the novel heat shock protein 90 inhibitor, IPI-504, in pancreatic cancer. Mol Cancer Ther. 2008; 7(10):3275-84. DOI: 10.1158/1535-7163.MCT-08-0508. View